Radiofrequency Ablation, Where It Stands in Interventional Radiology Today

Abstract

Radiofrequency ablation (RFA) is one of the first developed minimally invasive definitive cancer therapies. The safety and efficacy of RFA is well documented and has led to its incorporation into multiple international societal guidelines. By expanding on the body of knowledge acquired during the clinical use of RFA, alternative ablative technologies have emerged and are successfully competing for locoregional therapy market share. The adaption of newer ablative technologies is leading to a rapid decline in the utilization of RFA by interventional radiologists despite the lack of proven superiority. In their 2010 article, Hong and Georgiades stated “… RFA is likely to remain the mainstay of ablations for small tumors until sufficient experience emerges for the widespread acceptance for alternative ablative modalities.” Within a decade of this publication, has this time arrived?

Keywords

radiofrequency ablation - cancer - microwave ablation - cryoablation

• References

• 1 Marsolais AAJ. . Decision Resources Group Medtech 360 Interventional Oncology Devices. 2016 ;(April)
• 2 Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S179-S186
• 3 Christie RV, Loomis AL. The relation of frequency to the physiological effects of ultra-high frequency currents. J Exp Med 1929; 49 (02) 303-321
• 4 Rossi S, Fornari F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 1990; 76 (01) 54-57
• 5 McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25 (03) 267-270
• 6 McGahan JP, Brock JM, Tesluk H, Gu WZ, Schneider P, Browning PD. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol 1992; 3 (02) 291-297
• 7 Goldberg SN, Gazelle GS, Compton CC, McLoud TC. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995; 2 (09) 776-784
• 8 Lung Cancer: Clinical and Surgical Specifications. Balci AE. , ed. In: Lung Cancer: Clinical and Surgical Specifications. Turkey: Bentham Books; 2013. . doi.org/10.2174/97816080544281130101
• 9 Clinical N, Guidelines P, Guidelines N. Non-small cell lung 2018
• 10 Klotz LV, Winter H. Surgical treatment of stage I and II non-small cell lung cancer. Onkologe 2018; 24 (12) 1009-1014
• 11 Dupuy DE, Fernando HC, Hillman S. , et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer 2015; 121 (19) 3491-3498
• 12 Lencioni R, Crocetti L, Cioni R. , et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9 (07) 621-628
• 13 Healey TT, March BT, Baird G, Dupuy DE. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol 2017; 28 (02) 206-211
• 14 Macchi M, Belfiore MP, Floridi C. , et al. Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol 2017; 34 (05) 96
• 15 de Baere T, Tselikas L, Woodrum D. , et al. Evaluating cryoablation of metastatic lung tumors in patients-safety and efficacy the ECLIPSE trial-interim analysis at 1 year. J Thorac Oncol 2015; 10 (10) 1468-1474
• 16 Eiken PW, De Baere T, Deschamps F. , et al. Multi-center study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE): preliminary safety outcomes. Cardiovasc Intervent Radiol 2016;
• 17 Jiang B, Mcclure MA, Chen T, Chen S. Efficacy and safety of thermal ablation of lung malignancies: a network meta-analysis. Ann Thorac Med 2018; 13 (04) 243-250
• 18 Borie F, Bouvier AM, Herrero A. , et al. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 2008; 98 (07) 505-509
• 19 Clancy C, Burke JP, Barry M, Kalady MF, Calvin Coffey J. A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival. Ann Surg Oncol 2014; 21 (12) 3900-3908
• 20 Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19 (03) 329-338
• 21 Dufour JF, Greten TF, Raymond E. , et al. Clinical Practice Guidelines EASL – EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma European Organisation for Research and Treatment of Cancer. J Hepatol 2012; 56 (04) 908-943
• 22 Omata M, Lesmana LA, Tateishi R. , et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4 (02) 439-474
• 23 Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998; 27 (01) 67-72
• 24 Feng K, Yan J, Li X. , et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 2012; 57 (04) 794-802
• 25 Fang Y, Chen W, Liang X. , et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma. J Gastroenterol Hepatol 2014; 29 (01) 193-200
• 26 Huang J, Yan L, Cheng Z. , et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252 (06) 903-912
• 27 Ruers T, Van Coevorden F, Punt CJA. , et al; European Organisation for Research and Treatment of Cancer (EORTC); Gastro-Intestinal Tract Cancer Group; Arbeitsgruppe Lebermetastasen und tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG). Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst 2017; 109 (09)
• 28 Vogl TJ, Farshid P, Naguib NNN. , et al. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging 2015; 40 (06) 1829-1837
• 29 Zhang L, Wang N, Shen Q, Cheng W, Qian GJ. Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma. PLoS One 2013; 8 (10) e76119
• 30 Lu MD, Xu HX, Xie XY. , et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 2005; 40 (11) 1054-1060
• 31 Ding J, Jing X, Liu J. , et al. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma. Eur J Radiol 2013; 82 (09) 1379-1384
• 32 Abdelaziz A, Elbaz T, Shousha HI. , et al. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience. Surg Endosc 2014; 28 (12) 3429-3434
• 33 Vietti Violi N, Duran R, Guiu B. , et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol 2018; 3 (05) 317-325
• 34 Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23 (02) 109-113 , discussion 113–114
• 35 Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60 (2, Suppl 1): 40-49
• 36 Wang C, Wang H, Yang W. , et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology 2015; 61 (05) 1579-1590
• 37 McCarley JR, Soulen MC. Percutaneous ablation of hepatic tumors. Semin Intervent Radiol 2010; 27 (03) 255-260
• 38 Fairchild AH, Tatli S, Dunne RM, Shyn PB, Tuncali K, Silverman SG. Percutaneous cryoablation of hepatic tumors adjacent to the gallbladder: assessment of safety and effectiveness. J Vasc Interv Radiol 2014; 25 (09) 1449-1455
• 39 Kim GM, Won JY, Kim MD. , et al. Cryoablation of hepatocellular carcinoma with high-risk for percutaneous ablation: safety and efficacy. Cardiovasc Intervent Radiol 2016; 39 (10) 1447-1454
• 40 Campbell S, Uzzo RG, Allaf ME. , et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017; 198 (03) 520-529
• 41 Ljungberg B, Albiges L, Abu-Ghanem Y. , et al. European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 update. Eur Urol 2019; 75 (05) 799-810
• 42 Weis S, Franke A, Mössner J, Jakobsen JC, Schoppmeyer K. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev 2013; (12) CD003046
• 43 Ferakis N, Bouropoulos C, Granitsas T, Mylona S, Poulias I. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J Endourol 2010; 24 (12) 1909-1913
• 44 Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 2011; 77 (06) 1393-1397
• 45 Stern JM, Svatek R, Park S. , et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int 2007; 100 (02) 287-290
• 46 Chang X, Liu T, Zhang F. , et al. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis. J Endourol 2015; 29 (05) 518-525
• 47 Guan W, Bai J, Liu J. , et al. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results. J Surg Oncol 2012; 106 (03) 316-321
• 48 Cornelis F, Grenier N, Moonen CT, Quesson B. In vivo characterization of tissue thermal properties of the kidney during local hyperthermia induced by MR-guided high-intensity focused ultrasound. NMR Biomed 2011; 24 (07) 799-806
• 49 Thompson SM, Schmitz JJ, Thompson RH. , et al. Introduction of microwave ablation into a renal ablation practice: valuable lessons learned. AJR Am J Roentgenol 2018; 211 (06) 1381-1389
• 50 Pirasteh A, Snyder L, Boncher N, Passalacqua M, Rosenblum D, Prologo JD. Cryoablation vs. radiofrequency ablation for small renal masses. Int Braz J Urol 2010; 36 (05) 632
• 51 Georgiades CS, Rodriguez R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Intervent Radiol 2014; 37 (06) 1494-1499
• 52 Thompson RH, Atwell T, Schmit G. , et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015; 67 (02) 252-259
• 53 Atwell TD, Schmit GD, Boorjian SA. , et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 2013; 200 (02) 461-466
• 54 Tillotson CL, Rosenberg AE, Rosenthal DI. Controlled thermal injury of bone. Report of a percutaneous technique using radiofrequency electrode and generator. Invest Radiol 1989; 24 (11) 888-892
• 55 Rosenthal DI, Alexander A, Rosenberg AE, Springfield D. Ablation of osteoid osteomas with a percutaneously placed electrode: a new procedure. Radiology 1992; 183 (01) 29-33
• 56 Motamedi D, Learch TJ, Ishimitsu DN. , et al. Thermal ablation of osteoid osteoma: overview and step-by-step guide. Radiographics 2009; 29 (07) 2127-2141
• 57 Callstrom MR, Charboneau JW, Goetz MP. , et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology 2002; 224 (01) 87-97
• 58 Goetz MP, Callstrom MR, Charboneau JW. , et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004; 22 (02) 300-306
• 59 Callstrom MR, Charboneau JW, Goetz MP. , et al. Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol 2006; 35 (01) 1-15
• 60 Wu JSY, Wong R, Johnston M, Bezjak A, Whelan T. ; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003; 55 (03) 594-605
• 61 Kurup AN, Morris JM, Callstrom MR. Ablation of musculoskeletal metastases. AJR Am J Roentgenol 2017; 209 (04) 713-721
• 62 Munk PL, Rashid F, Heran MK. , et al. Combined cementoplasty and radiofrequency ablation in the treatment of painful neoplastic lesions of bone. J Vasc Interv Radiol 2009; 20 (07) 903-911
• 63 Lane MD, Le HBQ, Lee S. , et al. Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patients. Skeletal Radiol 2011; 40 (01) 25-32
• 64 Food and Drug Administration, HHS. Unique device identification system. Final rule. Fed Regist 2013; 78 (185) 58785-58828
• 65 Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database--update and key issues. N Engl J Med 2011; 364 (09) 852-860
• 66 Gupta A, Huettner DP, Dukewich M. Comparative effectiveness review of cooled versus pulsed radiofrequency ablation for the treatment of knee osteoarthritis: a systematic review. Pain Physician 2017; 20 (03) 155-171
• 67 Chuter GSJ, Chua YP, Connell DA, Blackney MC. Ultrasound-guided radiofrequency ablation in the management of interdigital (Morton's) neuroma. Skeletal Radiol 2013; 42 (01) 107-111
• 68 Heidelbaugh JJ, Lee H. Management of the ingrown toenail. Am Fam Physician 2009; 79 (04) 303-308
• 69 Ganz RA, Utley DS, Stern RA, Jackson J, Batts KP, Termin P. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 2004; 60 (06) 1002-1010
• 70 Fleischer DE, Overholt BF, Sharma VK. , et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 2010; 42 (10) 781-789
• 71 Noar MD, Noar E. Gastroparesis associated with gastroesophageal reflux disease and corresponding reflux symptoms may be corrected by radiofrequency ablation of the cardia and esophagogastric junction. Surg Endosc 2008; 22 (11) 2440-2444
• 72 Goldstone RN, Hasan SR, Goldstone SE. Radiofrequency ablation therapy for anal intraepithelial neoplasia: results from a single-center prospective pilot study in HIV+ participants. J Acquir Immune Defic Syndr 2017; ;1; 76 (04) e93-e97
• 73 Krueger N, Sadick NS. New-generation radiofrequency technology. Cutis 2013; 91 (01) 39-46
• 74 Bäck LJJ, Hytönen ML, Roine RP, Malmivaara AOV. Radiofrequency ablation treatment of soft palate for patients with snoring: a systematic review of effectiveness and adverse effects. Laryngoscope 2009; 119 (06) 1241-1250
• 75 Stuck BA, Sauter A, Hörmann K, Verse T, Maurer JT. Radiofrequency surgery of the soft palate in the treatment of snoring. A placebo-controlled trial. Sleep 2005; 28 (07) 847-850
• 76 Lee BB, Yu SP. Radiofrequency ablation of uterine fibroids: a review. Curr Obstet Gynecol Rep 2016; 5 (04) 318-324
• 77 Paramasivam G, Wimalasundera R, Wiechec M, Zhang E, Saeed F, Kumar S. Radiofrequency ablation for selective reduction in complex monochorionic pregnancies. BJOG 2010; 117 (10) 1294-1298